Canada Enteral Nutrition Market
The Canada Enteral Nutrition Market size was valued at CA$ 514.33 Mn in 2023 and is projected to reach CA$ 817.11 Mn by 2031, growing at a CAGR of 6.0% during 2022 - 2030.
Report Coverage
- Disease Indication: Orthopedic Disorders, Cardiovascular Disorders, Oncology, Neurological Disorders
- Formula Type: Standard Formulas, Peptide Formulas, Specialized Formulas
- Route of Administration: Oral, Tube Feed
- End User: Long Term Care Facilities, Hospitals
CA$ 514.33 Mn
Market size in 2023
CA$ 817.11 Mn
Market Size by 2031
6.0%
CAGR, 2022 - 2030
2024-2031
Forecast Period
1. Introduction
1.1 Report Guidance
1.2 Market Segmentation
2. Executive Summary
2.1 Key Market Insights
2.2 Market Attractiveness
3. Research Methodology
3.1 Secondary Research
3.2 Primary Research
- 3.2.1 Data Triangulation and Validation
4. Canada Enteral Nutrition Market Landscape
4.1 Overview
4.3 Ecosystem Analysis
- 4.3.1 List of Vendors in the Value Chain
5. Canada Enteral Nutrition Market – Key Market Dynamics
5.1 Market Drivers
5.2 Market Restraints
5.3 Market Opportunities
5.4 Future Trends
5.5 Impact of Drivers and Restraints
6. Canada Enteral Nutrition Market Regional Analysis
6.2 Canada Enteral Nutrition Market Revenue 2021-2031 (US$ Million)
6.3 Canada Enteral Nutrition Market Forecast Analysis
7. Canada Enteral Nutrition Market Analysis – by Disease Indication
7.1 Orthopedic Disorders
- 7.1.1 Overview
- 7.1.2 Orthopedic Disorders: Canada Enteral Nutrition Market – Revenue and Forecast, 2021-2031 (US$ Million)
7.2 Cardiovascular Disorders
- 7.2.1 Overview
- 7.2.2 Cardiovascular Disorders: Canada Enteral Nutrition Market – Revenue and Forecast, 2021-2031 (US$ Million)
7.3 Oncology
- 7.3.1 Overview
- 7.3.2 Oncology: Canada Enteral Nutrition Market – Revenue and Forecast, 2021-2031 (US$ Million)
7.4 Neurological Disorders
- 7.4.1 Overview
- 7.4.2 Neurological Disorders: Canada Enteral Nutrition Market – Revenue and Forecast, 2021-2031 (US$ Million)
8. Canada Enteral Nutrition Market Analysis – by Formula Type
8.1 Standard Formulas
- 8.1.1 Overview
- 8.1.2 Standard Formulas: Canada Enteral Nutrition Market – Revenue and Forecast, 2021-2031 (US$ Million)
8.2 Peptide Formulas
- 8.2.1 Overview
- 8.2.2 Peptide Formulas: Canada Enteral Nutrition Market – Revenue and Forecast, 2021-2031 (US$ Million)
8.3 Specialized Formulas
- 8.3.1 Overview
- 8.3.2 Specialized Formulas: Canada Enteral Nutrition Market – Revenue and Forecast, 2021-2031 (US$ Million)
9. Canada Enteral Nutrition Market Analysis – by Route of Administration
9.1 Oral
- 9.1.1 Overview
- 9.1.2 Oral: Canada Enteral Nutrition Market – Revenue and Forecast, 2021-2031 (US$ Million)
9.2 Tube Feed
- 9.2.1 Overview
- 9.2.2 Tube Feed: Canada Enteral Nutrition Market – Revenue and Forecast, 2021-2031 (US$ Million)
10. Canada Enteral Nutrition Market Analysis – by End User
10.1 Long Term Care Facilities
- 10.1.1 Overview
- 10.1.2 Long Term Care Facilities: Canada Enteral Nutrition Market – Revenue and Forecast, 2021-2031 (US$ Million)
10.2 Hospitals
- 10.2.1 Overview
- 10.2.2 Hospitals: Canada Enteral Nutrition Market – Revenue and Forecast, 2021-2031 (US$ Million)
11. Canada Enteral Nutrition Market – Canada Analysis
11.1 Overview
11.2 Canada- 11.2.1 Canada Enteral Nutrition Market Breakdown, by Key Country, 2024 and 2031 (%)
- 11.2.1.1 Canada Enteral Nutrition Market – Revenue and Forecast Analysis – by Country
- 11.2.1.1 Canada: Canada Enteral Nutrition Market – Revenue and Forecast to 2031 (US$ Million)
- 11.2.1.1.1 Canada: Canada Enteral Nutrition Market Breakdown, by Disease Indication
- 11.2.1.1.2 Canada: Canada Enteral Nutrition Market Breakdown, by Formula Type
- 11.2.1.1.3 Canada: Canada Enteral Nutrition Market Breakdown, by Route of Administration
- 11.2.1.1.4 Canada: Canada Enteral Nutrition Market Breakdown, by End User
12. Competitive Landscape
12.1 Heat Map Analysis
12.2 Company Positioning and Concentration
13. Industry Landscape
13.1 Overview
13.2 Market Initiative
13.3 Partnerships and Collaborations
13.4 Other Developments
14. Company Profiles
14.1 Nestle SA
- 14.1.1 Key Facts
- 14.1.2 Business Description
- 14.1.3 Products and Services
- 14.1.4 Financial Overview
- 14.1.5 SWOT Analysis
- 14.1.6 Key Developments
14.2 Abbott Laboratories
- 14.2.1 Key Facts
- 14.2.2 Business Description
- 14.2.3 Products and Services
- 14.2.4 Financial Overview
- 14.2.5 SWOT Analysis
- 14.2.6 Key Developments
14.3 Fresenius Medical Care AG & Co KgaA
- 14.3.1 Key Facts
- 14.3.2 Business Description
- 14.3.3 Products and Services
- 14.3.4 Financial Overview
- 14.3.5 SWOT Analysis
- 14.3.6 Key Developments
14.4 Koninklijke DSM NV
- 14.4.1 Key Facts
- 14.4.2 Business Description
- 14.4.3 Products and Services
- 14.4.4 Financial Overview
- 14.4.5 SWOT Analysis
- 14.4.6 Key Developments
14.5 B Barun SE
- 14.5.1 Key Facts
- 14.5.2 Business Description
- 14.5.3 Products and Services
- 14.5.4 Financial Overview
- 14.5.5 SWOT Analysis
- 14.5.6 Key Developments
15. Appendix
15.1 About Business Market Insights
15.2 List of Abbreviations
Access the Full C Market Report
Get segment-level forecasts, regional estimates, competitive benchmarking, company profiles and downloadable Excel datasets.
